Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Re: ISIS performance profile Pharma Comparison

The move from $8 to $13 occurred because the FDA said ACAD would not have to run a confirmatory trial.

Share
New Message
Please login to post a reply